Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Chris Shibutani is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/14/2025 | MCRB | Buy Now | Seres Therapeutics | $0.77 | -2.6% | Chris Shibutani54% | $1 → $0.75 | Maintains | Sell | Get Alert |
| 02/14/2025 | ALKS | Buy Now | Alkermes | $33.03 | -3.12% | Chris Shibutani54% | $30 → $32 | Maintains | Buy | Get Alert |
| 12/20/2024 | PCVX | Buy Now | Vaxcyte | $76.14 | 77.3% | Chris Shibutani54% | → $135 | Initiates | → Buy | Get Alert |
| 11/08/2024 | BNTX | Buy Now | BioNTech | $99.01 | 38.37% | Chris Shibutani54% | $90 → $137 | Upgrade | Neutral → Buy | Get Alert |
| 11/07/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.14 | 151.14% | Chris Shibutani54% | $30 → $33 | Maintains | Buy | Get Alert |
| 11/01/2024 | UTHR | Buy Now | United Therapeutics | $318.86 | -5.29% | Chris Shibutani54% | $243 → $302 | Maintains | Neutral | Get Alert |
| 10/25/2024 | ALKS | Buy Now | Alkermes | $33.03 | -9.17% | Chris Shibutani54% | $32 → $30 | Maintains | Buy | Get Alert |
| 10/25/2024 | ERAS | Buy Now | Erasca | $1.49 | 134.9% | Chris Shibutani54% | $3 → $3.5 | Maintains | Buy | Get Alert |
| 08/14/2024 | ERAS | Buy Now | Erasca | $1.49 | 101.34% | Chris Shibutani54% | $4 → $3 | Maintains | Buy | Get Alert |
| 08/14/2024 | RPRX | Buy Now | Royalty Pharma | $33.54 | 52.06% | Chris Shibutani54% | $50 → $51 | Maintains | Buy | Get Alert |
| 07/19/2024 | JNJ | Buy Now | Johnson & Johnson | $163.00 | -4.91% | Chris Shibutani54% | $160 → $155 | Maintains | Neutral | Get Alert |
| 07/12/2024 | AMLX | Buy Now | Amylyx Pharma | $3.65 | 9.59% | Chris Shibutani54% | $3 → $4 | Maintains | Neutral | Get Alert |
| 05/28/2024 | ERAS | Buy Now | Erasca | $1.49 | 168.46% | Chris Shibutani54% | $7 → $4 | Maintains | Buy | Get Alert |
| 05/13/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani54% | $9 → $8 | Maintains | Neutral | Get Alert |
| 05/06/2024 | OGN | Buy Now | Organon | $15.87 | 26.02% | Chris Shibutani54% | $18 → $20 | Maintains | Neutral | Get Alert |
| 05/03/2024 | UTHR | Buy Now | United Therapeutics | $318.86 | -24.73% | Chris Shibutani54% | $218 → $240 | Maintains | Neutral | Get Alert |
| 05/03/2024 | OGN | Buy Now | Organon | $15.87 | 26.02% | Chris Shibutani54% | $18 → $20 | Maintains | Neutral | Get Alert |
| 04/11/2024 | LLY | Buy Now | Eli Lilly and Co | $839.90 | -13.92% | Chris Shibutani54% | $650 → $723 | Maintains | Neutral | Get Alert |
| 04/02/2024 | ERAS | Buy Now | Erasca | $1.49 | 369.8% | Chris Shibutani54% | $6 → $7 | Maintains | Buy | Get Alert |
| 03/11/2024 | AMLX | Buy Now | Amylyx Pharma | $3.65 | 9.59% | Chris Shibutani54% | $40 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 03/01/2024 | SDGR | Buy Now | Schrodinger | $22.51 | 15.5% | Chris Shibutani54% | $29 → $26 | Maintains | Neutral | Get Alert |
| 03/01/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani54% | $8 → $9 | Maintains | Neutral | Get Alert |
| 02/28/2024 | BNTX | Buy Now | BioNTech | $99.01 | 1% | Chris Shibutani54% | $113 → $100 | Maintains | Neutral | Get Alert |
| 02/20/2024 | RPRX | Buy Now | Royalty Pharma | $33.54 | 49.08% | Chris Shibutani54% | $56 → $50 | Maintains | Buy | Get Alert |
| 02/20/2024 | OGN | Buy Now | Organon | $15.87 | 13.42% | Chris Shibutani54% | $16 → $18 | Maintains | Neutral | Get Alert |
| 02/12/2024 | UTHR | Buy Now | United Therapeutics | $318.86 | -32.57% | Chris Shibutani54% | $213 → $215 | Upgrade | Sell → Neutral | Get Alert |
| 01/25/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.71 | 39.46% | Chris Shibutani54% | $134 → $153 | Maintains | Buy | Get Alert |
| 01/09/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani54% | $30 → $8 | Downgrade | Buy → Neutral | Get Alert |
| 12/11/2023 | ABBV | Buy Now | AbbVie | $212.25 | -18.49% | Chris Shibutani54% | → $173 | Upgrade | Neutral → Buy | Get Alert |
| 11/10/2023 | AMLX | Buy Now | Amylyx Pharma | $3.65 | 995.89% | Chris Shibutani54% | $46 → $40 | Maintains | Buy | Get Alert |
| 11/09/2023 | NKTR | Buy Now | Nektar Therapeutics | $0.88 | — | Chris Shibutani54% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/03/2023 | MCRB | Buy Now | Seres Therapeutics | $0.77 | 62.34% | Chris Shibutani54% | $4 → $1.25 | Maintains | Sell | Get Alert |
| 11/03/2023 | OGN | Buy Now | Organon | $15.87 | 0.82% | Chris Shibutani54% | $33 → $16 | Downgrade | Buy → Neutral | Get Alert |
| 10/30/2023 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 15% | Chris Shibutani54% | $81 → $69 | Maintains | Buy | Get Alert |
| 10/11/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.14 | 128.31% | Chris Shibutani54% | → $30 | Initiates | → Buy | Get Alert |
| 09/21/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani54% | $38 → $33 | Maintains | Buy | Get Alert |
| 08/10/2023 | LLY | Buy Now | Eli Lilly | $839.90 | -44.04% | Chris Shibutani54% | $385 → $470 | Maintains | Neutral | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $839.90 | -44.04% | Chris Shibutani54% | $385 → $470 | Maintains | Neutral | Get Alert |
| 07/24/2023 | AMLX | Buy Now | Amylyx Pharma | $3.65 | 1242.47% | Chris Shibutani54% | $45 → $49 | Upgrade | Neutral → Buy | Get Alert |
| 05/16/2023 | ERAS | Buy Now | Erasca | $1.49 | 504.03% | Chris Shibutani54% | $10 → $9 | Maintains | Buy | Get Alert |
| 05/10/2023 | EQRX | Buy Now | EQRx | — | — | Chris Shibutani54% | $5 → $3 | Maintains | Neutral | Get Alert |
| 03/28/2023 | BNTX | Buy Now | BioNTech | $99.01 | 41.4% | Chris Shibutani54% | $156 → $140 | Maintains | Neutral | Get Alert |
| 03/14/2023 | AMLX | Buy Now | Amylyx Pharma | $3.65 | 1187.67% | Chris Shibutani54% | $41 → $47 | Maintains | Neutral | Get Alert |
| 03/03/2023 | INVA | Buy Now | Innoviva | $17.15 | -24.2% | Chris Shibutani54% | $15 → $13 | Maintains | Neutral | Get Alert |
| 03/01/2023 | RVMD | Buy Now | Revolution Medicines | $38.75 | -40.65% | Chris Shibutani54% | $20 → $23 | Maintains | Neutral | Get Alert |
| 02/27/2023 | NKTR | Buy Now | Nektar Therapeutics | $0.88 | 127.25% | Chris Shibutani54% | $3 → $2 | Maintains | Sell | Get Alert |
| 02/24/2023 | ERAS | Buy Now | Erasca | $1.49 | 571.14% | Chris Shibutani54% | → $10 | Initiates | → Buy | Get Alert |
| 01/31/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Chris Shibutani54% | $117 → $144 | Maintains | Buy | Get Alert |
| 01/31/2023 | BNTX | Buy Now | BioNTech | $99.01 | 57.56% | Chris Shibutani54% | $177 → $156 | Maintains | Neutral | Get Alert |
| 12/19/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.36 | 3576.74% | Chris Shibutani54% | → $50 | Initiates | → Buy | Get Alert |
| 12/16/2022 | KYMR | Buy Now | Kymera Therapeutics | $33.87 | 53.53% | Chris Shibutani54% | $40 → $52 | Maintains | Buy | Get Alert |
| 12/13/2022 | PFE | Buy Now | Pfizer | $26.22 | 128.83% | Chris Shibutani54% | $47 → $60 | Upgrade | Neutral → Buy | Get Alert |
| 12/05/2022 | UTHR | Buy Now | United Therapeutics | $318.86 | -27.87% | Chris Shibutani54% | → $230 | Initiates | → Sell | Get Alert |
| 11/11/2022 | EQRX | Buy Now | EQRx | — | — | Chris Shibutani54% | $8 → $5 | Downgrade | Buy → Neutral | Get Alert |
| 11/08/2022 | TRDA | Buy Now | Entrada Therapeutics | $10.75 | 67.44% | Chris Shibutani54% | $13 → $18 | Maintains | Neutral | Get Alert |
| 11/08/2022 | LLY | Buy Now | Eli Lilly | $839.90 | -62.73% | Chris Shibutani54% | $281 → $313 | Maintains | Neutral | Get Alert |
| 11/08/2022 | BNTX | Buy Now | BioNTech | $99.01 | 78.77% | Chris Shibutani54% | $200 → $177 | Maintains | Neutral | Get Alert |
| 09/22/2022 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani54% | → $33 | Initiates | → Buy | Get Alert |
| 09/09/2022 | AMLX | Buy Now | Amylyx Pharma | $3.65 | 995.89% | Chris Shibutani54% | $22 → $40 | Maintains | Neutral | Get Alert |
| 08/16/2022 | TRDA | Buy Now | Entrada Therapeutics | $10.75 | 20.93% | Chris Shibutani54% | $10 → $13 | Maintains | Neutral | Get Alert |
| 08/03/2022 | KYMR | Buy Now | Kymera Therapeutics | $33.87 | 18.1% | Chris Shibutani54% | → $40 | Initiates | → Buy | Get Alert |
| 07/20/2022 | INVA | Buy Now | Innoviva | $17.15 | -6.71% | Chris Shibutani54% | → $16 | Initiates | → Neutral | Get Alert |
| 07/20/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Chris Shibutani54% | → $51 | Initiates | → Buy | Get Alert |
| 06/13/2022 | EQRX | Buy Now | EQRx | — | — | Chris Shibutani54% | → $8 | Initiates | → Buy | Get Alert |
| 05/24/2022 | EXAI | Buy Now | Exscientia | — | — | Chris Shibutani54% | $23 → $20 | Maintains | Buy | Get Alert |
| 05/24/2022 | TRDA | Buy Now | Entrada Therapeutics | $10.75 | -6.98% | Chris Shibutani54% | $22 → $10 | Maintains | Neutral | Get Alert |
| 05/24/2022 | BNTX | Buy Now | BioNTech | $99.01 | 108.06% | Chris Shibutani54% | $255 → $206 | Maintains | Neutral | Get Alert |
| 04/27/2022 | OGN | Buy Now | Organon | $15.87 | 152.05% | Chris Shibutani54% | → $40 | Initiates | → Buy | Get Alert |
| 04/27/2022 | RPRX | Buy Now | Royalty Pharma | $33.54 | 66.96% | Chris Shibutani54% | → $56 | Initiates | → Buy | Get Alert |
| 04/20/2022 | ALKS | Buy Now | Alkermes | $33.03 | 5.96% | Chris Shibutani54% | → $35 | Initiates | → Buy | Get Alert |
| 04/18/2022 | NKTR | Buy Now | Nektar Therapeutics | $0.88 | 240.87% | Chris Shibutani54% | → $3 | Downgrade | Neutral → Sell | Get Alert |
| 04/12/2022 | JNJ | Buy Now | Johnson & Johnson | $163.00 | 11.04% | Chris Shibutani54% | $163 → $181 | Maintains | Neutral | Get Alert |
| 04/12/2022 | LLY | Buy Now | Eli Lilly | $839.90 | -68.57% | Chris Shibutani54% | $234 → $264 | Maintains | Neutral | Get Alert |
| 04/12/2022 | ABBV | Buy Now | AbbVie | $212.25 | -34.04% | Chris Shibutani54% | $122 → $140 | Maintains | Neutral | Get Alert |
| 04/01/2022 | AMLX | Buy Now | Amylyx Pharma | $3.65 | 173.97% | Chris Shibutani54% | $36 → $10 | Downgrade | Buy → Neutral | Get Alert |
| 02/25/2022 | NBIX | Buy Now | Neurocrine Biosciences | $109.71 | 4.82% | Chris Shibutani54% | → $115 | Upgrade | Neutral → Buy | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $212.25 | -42.52% | Chris Shibutani54% | $117 → $122 | Maintains | Neutral | Get Alert |
| 02/01/2022 | AMLX | Buy Now | Amylyx Pharma | $3.65 | 886.3% | Chris Shibutani54% | → $36 | Initiates | → Buy | Get Alert |
| 12/17/2021 | ABBV | Buy Now | AbbVie | $212.25 | -46.76% | Chris Shibutani54% | → $113 | Initiates | → Neutral | Get Alert |
| 12/17/2021 | PFE | Buy Now | Pfizer | $26.22 | 94.51% | Chris Shibutani54% | → $51 | Initiates | → Neutral | Get Alert |
| 12/17/2021 | JNJ | Buy Now | Johnson & Johnson | $163.00 | -1.23% | Chris Shibutani54% | → $161 | Initiates | → Neutral | Get Alert |
| 12/17/2021 | LLY | Buy Now | Eli Lilly | $839.90 | -71.9% | Chris Shibutani54% | → $236 | Initiates | → Neutral | Get Alert |
| 12/17/2021 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 20% | Chris Shibutani54% | → $72 | Initiates | → Buy | Get Alert |
| 11/23/2021 | TRDA | Buy Now | Entrada Therapeutics | $10.75 | 169.77% | Chris Shibutani54% | → $29 | Initiates | → Neutral | Get Alert |
| 10/26/2021 | EXAI | Buy Now | Exscientia | — | — | Chris Shibutani54% | → $30 | Initiates | → Buy | Get Alert |
| 09/07/2021 | TNGX | Buy Now | Tango Therapeutics | $1.68 | 911.9% | Chris Shibutani54% | → $17 | Initiates | → Buy | Get Alert |
| 08/12/2021 | RVMD | Buy Now | Revolution Medicines | $38.75 | -30.32% | Chris Shibutani54% | $49 → $27 | Downgrade | Buy → Neutral | Get Alert |
| 07/23/2021 | MCRB | Buy Now | Seres Therapeutics | $0.77 | 809.09% | Chris Shibutani54% | $24 → $7 | Downgrade | Neutral → Sell | Get Alert |
| 05/18/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Chris Shibutani54% | → $90 | Initiates | → Buy | Get Alert |
| 05/18/2021 | BNTX | Buy Now | BioNTech | $99.01 | 74.73% | Chris Shibutani54% | → $173 | Initiates | → Neutral | Get Alert |
| 05/18/2021 | RVMD | Buy Now | Revolution Medicines | $38.75 | 26.45% | Chris Shibutani54% | → $49 | Initiates | → Buy | Get Alert |
| 07/14/2020 | RPTX | Buy Now | Repare Therapeutics | $1.11 | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 02/10/2020 | ARDX | Buy Now | Ardelyx | $5.35 | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 01/10/2020 | ADRO | Buy Now | Aduro Biotech | — | — | Chris Shibutani54% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/15/2019 | ALKS | Buy Now | Alkermes | $33.03 | -18.26% | Chris Shibutani54% | → $27 | Upgrade | Sell → Neutral | Get Alert |
| 05/28/2019 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | -10% | Chris Shibutani54% | → $54 | Initiates | → Buy | Get Alert |
| 12/19/2018 | ALKS | Buy Now | Alkermes | $33.03 | -21.28% | Chris Shibutani54% | $49 → $26 | Downgrade | Neutral → Sell | Get Alert |
| 01/24/2018 | PBYI | Buy Now | Puma Biotechnology | $3.45 | — | Chris Shibutani54% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/21/2017 | MRTX | Buy Now | Mirati Therapeutics | — | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 11/07/2017 | NKTR | Buy Now | Nektar Therapeutics | $0.88 | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 07/18/2017 | ADRO | Buy Now | Aduro Biotech | — | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 05/25/2017 | PBYI | Buy Now | Puma Biotechnology | $3.45 | — | Chris Shibutani54% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 05/02/2017 | RDUS | Buy Now | Radius Health | $29.06 | — | Chris Shibutani54% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/24/2017 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 03/24/2017 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.14 | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 05/06/2016 | RDUS | Buy Now | Radius Health | $29.06 | — | Chris Shibutani54% | — | Assumes | → Outperform | Get Alert |
| 07/21/2015 | MCRB | Buy Now | Seres Therapeutics | $0.77 | 4575.32% | Chris Shibutani54% | → $36 | Initiates | → Neutral | Get Alert |
| 05/05/2015 | PBYI | Buy Now | Puma Biotechnology | $3.45 | — | Chris Shibutani54% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/16/2014 | RDUS | Buy Now | Radius Health | $29.06 | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 01/05/2014 | ALKS | Buy Now | Alkermes | $33.03 | 12.02% | Chris Shibutani54% | $25 → $37 | Maintains | Neutral | Get Alert |
| 12/19/2012 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | -35% | Chris Shibutani54% | $40 → $39 | Maintains | Buy | Get Alert |
| 11/13/2012 | PBYI | Buy Now | Puma Biotech | $3.45 | — | Chris Shibutani54% | — | Initiates | → Outperform | Get Alert |
| 09/11/2012 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | -33.33% | Chris Shibutani54% | $38 → $40 | Upgrade | Buy → Buy | Get Alert |
| 05/18/2012 | ALKS | Buy Now | Alkermes | $33.03 | -48.53% | Chris Shibutani54% | $18 → $17 | Maintains | Neutral | Get Alert |
